Genetic heterogeneity in partial adenosine deaminase deficiency
Insights
Partial adenosine deaminase (ADA) deficiency in immunologically normal children reveals genetic heterogeneity. Three distinct mutations in the ADA structural locus were identified, impacting enzyme properties and activity.
Area of Science:
- Biochemistry
- Immunology
- Genetics
Background:
- Inherited adenosine deaminase (ADA) deficiency causes severe combined immunodeficiency (SCID).
- Partial ADA deficiency presents differently, with affected individuals retaining some enzyme activity in lymphoid cells.
- Understanding the genetic basis of partial ADA deficiency is crucial for distinguishing it from SCID.
Purpose of the Study:
- To investigate genetic heterogeneity in four unrelated children with partial ADA deficiency.
- To characterize ADA enzyme activity and properties in lymphoid cells from these individuals.
- To identify potential mutations at the ADA structural locus.
Main Methods:
- Analysis of adenosine deaminase (ADA) activity in lymphoid line cells.
- Electrophoretic mobility and isoelectric point (pI) determination of the ADA enzyme.
- Assessment of enzyme heat stability at 56°C.
Main Results:
- Three children showed evidence of distinct mutations at the ADA structural locus.
- Mutations resulted in altered enzyme properties: increased electrophoretic mobility, altered pI, and diminished heat stability.
- Enzyme activity varied significantly, from very low to almost normal levels.
Conclusions:
- Evidence suggests at least three different mutations at the ADA structural locus in the studied individuals.
- These mutations lead to varied biochemical and functional consequences of partial ADA deficiency.
- A regulatory locus mutation cannot be excluded for the fourth individual.
Abstract:
Inherited deficiency of the enzyme adenosine deaminase (ADA) results in a syndrome of severe combined immunodeficiency (SCID). Children with ADA- -SCID lack ADA in all cells and tissues. In contrast, a "partial" deficiency of ADA has been described in six immunologically normal children from four different "families." These children lack ADA in their erythrocytes but retain variable amounts of activity in their lymphoid cells. We have examined ADA activity in lymphoid line cells from four of these children, who are unrelated, for evidence of genetic heterogeneity. One child, who is Caucasian, has an enzyme with increased electrophoretic mobility, a diminished isoelectric point (pI 4.8 vs. Nl = 4.9) and very low activity (2.3 vs. Nl = 82.9 +/- 12.9 nmol/mg protein per min); as a second child has an enzyme with normal electrophoretic mobility but increased isoelectric point (pI = 5.0), markedly diminished heat stability at 56 degrees C (t1/2 = 4.2' vs. Nl = 40') and low activity (12.1); a third has an enzyme with only diminished heat stability (t1/2 = 6.5'), no detectable abnormality in charge and almost normal activity (41.9); while the fourth exhibits only diminished ADA activity (25.0) with no striking qualitative abnormalities. Thus, we have found evidence for three different mutations at the structural locus for ADA in three of these individuals, (a) an acidic, low activity heat stable mutation (b) a basic, somewhat higher activity, heat labile mutation, and (c) a relatively normal activity heat labile mutation. In the fourth, there is as yet no compelling evidence for a mutation at the structural locus for ADA and a mutation at a regulatory locus cannot be excluded.
Related Concept Videos
Multiple Allele Traits
Incomplete Dominance
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drug toxicity: Idiosyncratic Reactions


